Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1497 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Bruker Q2 Revenues Up 19%

Bruker has posted a net income of $22.6m for the second quarter 2010, or $0.14 per diluted share, compared to net income of $12.9, or $0.08 per diluted

VaxGen Completes Merger With diaDexus

Under the terms of merger agreement, diaDexus expects to operate as a wholly-owned subsidiary of VaxGen. VaxGen has issued approximately 19,960,534 shares to certain diaDexus stockholders and officers,

CMPT Names New CEO

Dr Mackenzie brings to CMPT a long record of executive board level management within the biotechnology and pharmaceutical industries at companies including Cambridge Genetics Ltd, Oxford Biomedica plc

PDL BioPharma Q2 Revenues Decline

PDL BioPharma has posted a net income of $50.1m for the second quarter 2010, or $0.30 per diluted share, compared to net income of $77.2m, or $0.47 per

Nutraloid Recalls Two Dietary Supplements

Sildenafil is an active ingredient of an FDA-approved drug for male Erectile Dysfunction (ED). FDA said that the undeclared ingredient may interact with nitrates found in some prescription